ISRCTN10495682进行中（未招募）Unknown
Personalised ANtiplatelet THERapy for patients with symptomatic Peripheral Arterial Disease (PANTHER-PAD)
niversity of Leicester0 个研究点目标入组 80 人开始时间: 2023年11月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Aged 18 years old and over
- •2. Severely symptomatic aorto-iliac and infra-inguinal peripheral arterial disease
- •3. Ability to provide written informed consent
- •4. Patients on antiplatelet therapy
排除标准
- •1. Aged 17 years old and under
- •2. Unable or unwilling to provide written informed consent
- •3. Acute limb ischaemia of the lower limb
- •4. Aneurysmal disease of the arteries of the lower limb
- •5. Severe diabetic foot sepsis
- •6. A known history of clotting disorders
- •7. Inherited bleeding disorders
研究者
相似试验
已完成
不适用
Controlled Anti-platelet medical therapy based on rapid CYP2C19 gene evaluation in Acute myocardial infarctioAcute myocardial infarctionJPRN-UMIN000008151Graduate School of Medical Sciences, Kumamoto University100
已完成
4 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioNL-OMON45158Sint Antonius Ziekenhuis500
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic stenosis for which a transcatheter aortic valve implantation (TAVI) is performed.MedDRA version: 19.1Level: PTClassification code 10002906Term: Aortic stenosisSystem Organ Class: 10047065 - Vascular disordersEUCTR2013-003125-28-GBSt. Antonius Hospital1,000
招募中
不适用
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic valve diseaseaortic valve stenosisbleedingthrombosisplatelet inhibitors.strokeNL-OMON25546St Antonius Hospital, Nieuwegein, the Netherlands1,000
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioEUCTR2013-003125-28-BESt. Antonius Hospital1,000